Kezar Life Sciences Future Growth
Future criteria checks 2/6
Kezar Life Sciences's earnings are forecast to decline at 4.3% per annum while its annual revenue is expected to grow at 46.8% per year. EPS is expected to grow by 6.2% per annum.
Key information
-4.3%
Earnings growth rate
6.2%
EPS growth rate
| Biotechs earnings growth | 23.7% |
| Revenue growth rate | 46.8% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 04 Apr 2024 |
Recent future growth updates
Recent updates
Is Kezar Life Sciences (NASDAQ:KZR) Using Debt Sensibly?
Dec 08
FDA clears Kezar Life Sciences' drug application for autoimmune hepatitis treatment
Oct 03Is Kezar Life Sciences (NASDAQ:KZR) Using Too Much Debt?
Aug 15Kezar Life Sciences GAAP EPS of -$0.25 beats by $0.02
Aug 11Kezar Life Sciences: Regulatory Tailwinds Reverse Downside Case
Jul 27Kezar Life Sciences appoints Nick Mordwinkin as chief business officer
Jul 11We're Not Very Worried About Kezar Life Sciences' (NASDAQ:KZR) Cash Burn Rate
Jan 03Here's Why We're Not Too Worried About Kezar Life Sciences' (NASDAQ:KZR) Cash Burn Situation
Aug 26We're Not Very Worried About Kezar Life Sciences' (NASDAQ:KZR) Cash Burn Rate
Apr 05Here's What Kezar Life Sciences, Inc.'s (NASDAQ:KZR) Shareholder Ownership Structure Looks Like
Mar 01Kezar Life Sciences, Inc. (NASDAQ:KZR) Insiders Increased Their Holdings
Jan 25Kezar Life Sciences (NASDAQ:KZR) Is In A Good Position To Deliver On Growth Plans
Dec 21
Kezar Life Sciences selected for the Nasdaq Biotechnology Index
Dec 14Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | N/A | -137 | N/A | -116 | 4 |
| 12/31/2025 | 3 | -111 | N/A | -115 | 6 |
| 12/31/2024 | 2 | -102 | N/A | -114 | 6 |
| 12/31/2023 | 7 | -102 | -83 | -82 | N/A |
| 9/30/2023 | 7 | -88 | -81 | -79 | N/A |
| 6/30/2023 | N/A | -83 | -77 | -75 | N/A |
| 3/31/2023 | N/A | -74 | -68 | -66 | N/A |
| 12/31/2022 | N/A | -68 | -60 | -59 | N/A |
| 9/30/2022 | N/A | -64 | -56 | -54 | N/A |
| 6/30/2022 | N/A | -61 | -49 | -48 | N/A |
| 3/31/2022 | N/A | -58 | -48 | -47 | N/A |
| 12/31/2021 | N/A | -55 | -43 | -42 | N/A |
| 9/30/2021 | N/A | -51 | -41 | -41 | N/A |
| 6/30/2021 | N/A | -48 | -40 | -40 | N/A |
| 3/31/2021 | N/A | -45 | -37 | -37 | N/A |
| 12/31/2020 | N/A | -42 | -37 | -37 | N/A |
| 9/30/2020 | N/A | -40 | -35 | -35 | N/A |
| 6/30/2020 | N/A | -38 | -34 | -34 | N/A |
| 3/31/2020 | N/A | -37 | -32 | -31 | N/A |
| 12/31/2019 | N/A | -35 | -30 | -30 | N/A |
| 9/30/2019 | N/A | -31 | -29 | -28 | N/A |
| 6/30/2019 | N/A | -28 | -25 | -24 | N/A |
| 3/31/2019 | N/A | -26 | -25 | -24 | N/A |
| 12/31/2018 | N/A | -23 | -22 | -21 | N/A |
| 9/30/2018 | N/A | -20 | -18 | -17 | N/A |
| 6/30/2018 | N/A | -16 | -16 | -15 | N/A |
| 3/31/2018 | N/A | -11 | -10 | -10 | N/A |
| 12/31/2017 | N/A | -9 | -8 | -8 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: KZR is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: KZR is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: KZR is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: KZR's revenue (46.8% per year) is forecast to grow faster than the US market (8.2% per year).
High Growth Revenue: KZR's revenue (46.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if KZR's Return on Equity is forecast to be high in 3 years time